SPC
BHC icon

Slate Path Capital’s Bausch Health BHC Stock Holding History

Slate Path Capital’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,245,000
Closed -$65.8M – 34
2020
Q1 		$65.8M Sell
4,245,000
-1,334,948
-24% -$32.2M 5.05% 9
2019
Q4 		$167M Buy
+5,579,948
New +$145M 8.99% 4

Other funds holding BHC

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Slate Path Capital's BHC Position: Q2 2020 in Review

Slate Path Capital sold out of Bausch Health (BHC) in Q2 2020, closing a stake of 4,245,000 shares — an estimated $65.8M sold.

Slate Path Capital first reported a position in BHC in Q4 2019 and held it in 2 quarters. The position peaked at $167M in Q4 2019. 303 funds tracked by Wall St. Rank hold BHC as of Q2 2020.

  • Slate Path Capital reported no remaining Bausch Health position as of Q2 2020 after selling out during the quarter.
  • Slate Path Capital sold 4,245,000 Bausch Health shares in Q2 2020, an estimated $65.8M.
  • Slate Path Capital first reported a position in Bausch Health in Q4 2019 and held it in 2 quarters.
  • Slate Path Capital's Bausch Health position peaked at $167M in Q4 2019.
  • 303 funds tracked by Wall St. Rank held Bausch Health as of Q2 2020.

Based on Slate Path Capital's 13F filing for Q2 2020, filed 14 Aug 2020.